Photo de VIH/SIDA

VIH/SIDA

Erick Ntambwe Kamangu, Adawaye Chatte, Raphael Boreux, Fabrice Susin, Richard Lunganza Kalala, Georges Lelo Mvumbi, Patrick De Mol, Marie-Pierre Hayette, Dolores Vaira. Comparison of an In-House Quantitative PCR and COBAS Ampliprep/TaqMan Roche for Determination of Viral Load for HIV Type 1 non-B. Open Access Library Journal. 2015, 2: e1402.

 Erick Ntambwe Kamangu, Hypolite Mavoko Muhindo, Carole Weba Wapa-Kamangu, Hippolyte Nani-Tuma Situakibanza. Prevalence of Malaria Infection among People Living with HIV in Kinshasa. Open Access Library Journal. 2015, 2: e1077.

Erick Ntambwe Kamangu, Adawaye Chatte, Raphael Boreux, Richard Lunganza Kalala, Georges Lelo Mvumbi, Patrick Demol, Dolores Vaira, Pierre Marie Hayette. Implementation of an In-House Quantitative Real-Time PCR for Determination of HIV Viral Load in Kinshasa. Open Access Library Journal. 2014. 1: e855.

N. E. Kamangu, M. E. Kawila, H. Mukumbi and L. G. Mvumbi, “Estimated Rates of Treatment Failure in FirstLine Antiretroviral Treatment in Kinshasa: Case of ACSAMO-Congo,” IJCRIMPH, Vol. 4, No. 6, 2012, pp. 885-
891

Erick Ntambwe Kamangu, Ben Ilunga Bulanda, Berry Ikolango Bongenia, Huguette Tshweka Botomwito, Georges Lelo Mvumbi, Patrick De Mol, Dolores Vaira, Marie-Pierre Hayette, Richard Lunganza Kalala (2015) Virological Profile of Patients Infected with HIV Starting Antiretroviral Treatment in Kinshasa. Open Access Library Journal,02,1-5. doi: 10.4236/oalib.1101564

Erick Ntambwe Kamangu, Richard Lunganza Kalala, Georges Lelo Mvumbi, Dolores Vaira, Marie-Pierre Hayette. Involvement of the Genetic Diversity of HIV-1 in the Virological Treatment Failure of First Line Antiretroviral in Kinshasa. World Journal of AIDS, 2017, 7, 23-33

 Kamangu EN. (2016). Human Immunodeficiency Virus Type 1 and Type 2 Co-infection Rate in Kinshasa Patients. M J HIV 1(2): 009.

 Kamangu EN, Bulanda BI, Bongenia BI, Botomwito HT, Mvumbi GL, De Mol P,  Vaira D, Hayette MP & Kalala LR. Profil Epidémiologique Moléculaire de l’Infection à VIH de Type 1 chez les patients naïfs de traitement à Kinshasa. Ann Afr Med 2015, Vol 8: 4

Kamangu EN, Chatte A, Susin F, Boreux R, Kalala RL, et al. (2015) Genetic Diversity and Antiretroviral Drug Resistance among Drug-Naïve HIV Type 1 Infected Patients attending Clinics in Kinshasa, Democratic Republic of Congo. J HIV AIDS Volume1.1

 Kamangu Ntambwe Erick, Kabututu Zakayi, Mvumbi Lelo Georges, Kalala Lunganza Richard, Mesia Kahunu Gauthier. Genetic Diversity of Human Immunodeficiency Virus Type 1 in the Democratic Republic of Congo: a review of available data. Int J  Col Res Int Med & Pub Health 2013.5

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Retour en haut
Aller au contenu principal